Lupin Limited (NSE:LUPIN)
1,927.10
+7.30 (0.38%)
Sep 29, 2025, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 877.32 billion as of September 29, 2025. Its market cap has decreased by -13.46% in one year.
Market Cap
877.32B
Enterprise Value
902.80B
Revenue
233.76B
Ranking
n/a
PE Ratio
23.72
Stock Price
1,927.10
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 877.32B, an increase of 87,795.41%. That is a compound annual growth rate of 29.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 877.32B | -18.21% |
Dec 31, 2024 | 1,072.58B | 78.05% |
Dec 29, 2023 | 602.42B | 80.75% |
Dec 30, 2022 | 333.29B | -22.86% |
Dec 31, 2021 | 432.05B | -2.46% |
Dec 31, 2020 | 442.95B | 27.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,904.68B |
Divi's Laboratories | 1,565.47B |
Cipla | 1,219.47B |
Apollo Hospitals Enterprise | 1,096.21B |
Mankind Pharma | 1,042.71B |
Zydus Lifesciences | 1,025.60B |
Fortis Healthcare | 713.13B |
Alkem Laboratories | 649.60B |